Aurinia Pharmaceuticals Inc. - AUPH

SEC FilingsOur AUPH Tweets

About Gravity Analytica

Recent News

  • 05.22.2025 - New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis
  • 05.16.2025 - 4 - Statement of changes in beneficial ownership of securities
  • 05.16.2025 - 4 - Statement of changes in beneficial ownership of securities
  • 05.16.2025 - 4 - Statement of changes in beneficial ownership of securities
  • 05.16.2025 - 4 - Statement of changes in beneficial ownership of securities
  • 05.16.2025 - 3 - Initial statement of beneficial ownership of securities
  • 05.16.2025 - 3 - Initial statement of beneficial ownership of securities
  • 05.16.2025 - S-8 - Securities to be offered to employees in employee benefit plans
  • 05.15.2025 - 8-K - Current report
  • 05.12.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]

Recent Filings

  • 05.16.2025 - 3 Initial statement of beneficial ownership of securities
  • 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.16.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.16.2025 - 3 Initial statement of beneficial ownership of securities
  • 05.15.2025 - EX-99.1 EX-99.1
  • 05.15.2025 - 8-K Current report